{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:26:14Z","timestamp":1790270774978,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-023-02701-w","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T21:29:37Z","timestamp":1701293377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Levofloxacin\u2013Fatty Acid Systems: Dual Enhancement Through Deep Eutectic Formation and Solubilization for Pharmaceutical Potential and Antibacterial Activity"],"prefix":"10.1208","volume":"24","author":[{"given":"Bayan","family":"Alkhawaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7225-0936","authenticated-orcid":false,"given":"Faisal","family":"Al-Akayleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehad","family":"Nasereddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne Abdel","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Alkhawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid","family":"Al-Rubaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisa\u2019a","family":"Smairat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayyas","family":"Al-Remawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid Salem","family":"Aburayyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"2701_CR1","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.2165\/00003495-200363240-00008","volume":"63","author":"KF Croom","year":"2003","unstructured":"Croom KF, Goa KL. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. Drugs. 2003;63:2769\u2013802.","journal-title":"Drugs"},{"key":"2701_CR2","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.2165\/00003495-200262140-00013","volume":"62","author":"M Hurst","year":"2002","unstructured":"Hurst M, Lamb HM, Scott LJ, Figgitt DP. Levofloxacin: an updated review of its use in the treatment of bacterial infections. Drugs. 2002;62:2127\u201367.","journal-title":"Drugs"},{"key":"2701_CR3","doi-asserted-by":"publisher","unstructured":"Suaifan GARY, Mohammed AAM, Alkhawaja BA. Fluoroquinolones\u2019 biological activities against laboratory microbes and cancer cell lines. Molecules. 2022;27. https:\/\/doi.org\/10.3390\/molecules27051658.","DOI":"10.3390\/molecules27051658"},{"key":"2701_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.106103","volume":"170","author":"T Pulingam","year":"2022","unstructured":"Pulingam T, Parumasivam T, Gazzali AM, Sulaiman AM, Chee JY, Lakshmanan M, et al. Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur J Pharm Sci. 2022;170: 106103.","journal-title":"Eur J Pharm Sci"},{"key":"2701_CR5","unstructured":"Resolution WHA. 68.7. Global action plan on antimicrobial action. Sixty-eighth World Health Assembly, Agenda item 15.1, 26 May 2015. Geneva: World Health Organization. 2015. Available from: http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA68\/A68_R7-en.pdf?ua=1."},{"key":"2701_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/jgid.jgid_110_18","volume":"11","author":"A Chokshi","year":"2019","unstructured":"Chokshi A, Sifri Z, Cennimo D, Horng H. Global contributors to antibiotic resistance. J Glob Infect Dis. 2019;11:36.","journal-title":"J Glob Infect Dis"},{"key":"2701_CR7","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/ijms19041114","volume":"19","author":"BK Yoon","year":"2018","unstructured":"Yoon BK, Jackman JA, Valle-Gonz\u00e1lez ER, Cho NJ. Antibacterial free fatty acids and monoglycerides: biological activities, experimental testing, and therapeutic applications. Int J Molecul Sci. 2018;19:1114.","journal-title":"Int J Molecul Sci."},{"key":"2701_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/microorganisms10020301","volume":"10","author":"G Giovagnoni","year":"2022","unstructured":"Giovagnoni G, Tugnoli B, Piva A, Grilli E. Dual antimicrobial effect of medium-chain fatty acids against an Italian multidrug resistant Brachyspira hyodysenteriae strain. Microorganisms. 2022;10:301.","journal-title":"Microorganisms"},{"key":"2701_CR9","doi-asserted-by":"publisher","first-page":"e12050","DOI":"10.1371\/journal.pone.0012050","volume":"5","author":"A Murzyn","year":"2010","unstructured":"Murzyn A, Krasowska A, Stefanowicz P, Dziadkowiec D, \u0141ukaszewicz M. Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation. PLoS One. 2010;5:e12050.","journal-title":"PLoS One"},{"key":"2701_CR10","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s00253-009-2355-3","volume":"85","author":"AP Desbois","year":"2010","unstructured":"Desbois AP, Smith VJ. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol. 2010;85:1629\u201342.","journal-title":"Appl Microbiol Biotechnol"},{"key":"2701_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0928-8244(03)00008-7","volume":"36","author":"CQ Sun","year":"2003","unstructured":"Sun CQ, O\u2019Connor CJ, Roberton AM. Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol. 2003;36:9\u201317.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2701_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1034\/j.1600-0463.2001.d01-131.x","volume":"109","author":"G Bergsson","year":"2001","unstructured":"Bergsson G, Arnfinnsson J, Steingr\u00edmsson \u00d3, Thormar H. Killing of Gram-positive cocci by fatty acids and monoglycerides. APMIS. 2001;109:670\u20138.","journal-title":"APMIS"},{"key":"2701_CR13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1080\/0972060X.2015.1036569","volume":"18","author":"M Pal","year":"2015","unstructured":"Pal M, Mishra T, Kumar A, Baleshwar Upreti DK, Rana TS. Chemical constituents and antimicrobial potential of essential oil from Betula utilis growing in high altitude of Himalaya (India). J Essent Oil Bear Plants. 2015;18:1078\u201382.","journal-title":"J Essent Oil Bear Plants"},{"key":"2701_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/10412905.1995.9698464","volume":"7","author":"D Prudent","year":"1995","unstructured":"Prudent D, Perineau F, Bessiere JM, Michel G. Analysis of the essential oil of Pectis elongata Kunth. From Martinique. Evaluation of its Bacteriostatic and Fungistatic Properties. J Essent Oil Res. 1995;7:63\u20138.","journal-title":"J Essent Oil Res"},{"key":"2701_CR15","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.3390\/ijms23116261","volume":"23","author":"A Chrzanowska","year":"2022","unstructured":"Chrzanowska A, Struga M, Roszkowski P, Koli\u0144ski M, Kmiecik S, Ja\u0142brzykowska K, et al. The effect of conjugation of ciprofloxacin and moxifloxacin with fatty acids on their antibacterial and anticancer activity. Int J Mol Sci. 2022;23:6261.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"2701_CR16","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.3390\/molecules28196927","volume":"28","author":"DK Luhaibi","year":"2023","unstructured":"Luhaibi DK, Ali HHM, Al-Ani I, Shalan N, Al-Akayleh F, Al-Remawi M, Khanfar M. The formulation and evaluation of deep eutectic vehicles for the topical delivery of azelaic acid for acne treatment. Molecules. 2023;28(19):6927.","journal-title":"Molecules"},{"key":"2701_CR17","doi-asserted-by":"publisher","first-page":"108509","DOI":"10.1016\/j.microc.2023.108509","volume":"189","author":"V Andruch","year":"2023","unstructured":"Andruch V, Kalyniukova A, P\u0142otka-Wasylka J, Jatkowska N, Snigur D, Zaruba S, et al. Application of deep eutectic solvents in analytical sample pretreatment (update 2017\u20132022). Part A: liquid phase microextraction. Microchem J. 2023;189:108509.","journal-title":"Microchem J"},{"key":"2701_CR18","doi-asserted-by":"publisher","unstructured":"Al-Akayleh F, Adwan S, Khanfar M, et al. A novel eutectic-based transdermal delivery system for risperidone. AAPS PharmSciTech. 2021;4:22. https:\/\/doi.org\/10.1208\/s12249-020-01844-4.","DOI":"10.1208\/s12249-020-01844-4"},{"key":"2701_CR19","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1039\/c2cs15353j","volume":"41","author":"D Carriazo","year":"2012","unstructured":"Carriazo D, Serrano MC, Guti\u00e9rrez MC, Ferrer ML, del Monte F. Deep-eutectic solvents playing multiple roles in the synthesis of polymers and related materials. Chem Soc Rev. 2012;41:4996\u20135014.","journal-title":"Chem Soc Rev"},{"key":"2701_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1039\/B915049H","volume":"12","author":"M Deetlefs","year":"2010","unstructured":"Deetlefs M, Seddon KR. Assessing the greenness of some typical laboratory ionic liquid preparations. Green Chem. 2010;12:17\u201330.","journal-title":"Green Chem"},{"key":"2701_CR21","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.3390\/molecules28052402","volume":"28","author":"B Alkhawaja","year":"2023","unstructured":"Alkhawaja B, Al-Akayleh F, Al-Khateeb A, Nasereddin J, Ghanim BY, Bolhuis A, et al. Deep eutectic liquids as a topical vehicle for tadalafil: characterisation and potential wound healing and antimicrobial activity. Molecules. 2023;28:2402.","journal-title":"Molecules"},{"key":"2701_CR22","doi-asserted-by":"publisher","unstructured":"Al-Mawla L, Al-Akayleh F, Daadoue S, Mahyoob W, Al-Tameemi B, Al-Remawi M, Agha AS. Development, characterization, and ex vivo permeation assessment of diclofenac diethylamine deep eutectic systems across human skin. J Pharm Inn. 2023;1\u201314. https:\/\/doi.org\/10.1007\/s12247-023-09784-9.","DOI":"10.1007\/s12247-023-09784-9"},{"key":"2701_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2021.117347","volume":"345","author":"S Daadoue","year":"2022","unstructured":"Daadoue S, Al-Remawi M, Al-Mawla L, Idkaidek N, Khalid RM, Al-Akayleh F. Deep eutectic liquid as transdermal delivery vehicle of risperidone. J Mol Liq. 2022;345: 117347.","journal-title":"J Mol Liq"},{"key":"2701_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijpharm.2016.04.018","volume":"505","author":"Z Li","year":"2016","unstructured":"Li Z, Lee PI. Investigation on drug solubility enhancement using deep eutectic solvents and their derivatives. Int J Pharm. 2016;505:283\u20138.","journal-title":"Int J Pharm"},{"key":"2701_CR25","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1039\/C5MD00551E","volume":"7","author":"C Lu","year":"2016","unstructured":"Lu C, Cao J, Wang N, Su E. Significantly improving the solubility of non-steroidal anti- inflammatory drugs in deep eutectic solvents for potential non-aqueous liquid administration. Medchemcomm. 2016;7:955\u20139.","journal-title":"Medchemcomm"},{"key":"2701_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijpharm.2009.05.039","volume":"378","author":"HG Morrison","year":"2009","unstructured":"Morrison HG, Sun CC, Neervannan S. Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles. Int J Pharm. 2009;378:136\u20139.","journal-title":"Int J Pharm"},{"key":"2701_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1124\/pr.112.005660","volume":"65","author":"HD Williams","year":"2013","unstructured":"Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, et al. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 2013;65:315\u2013499.","journal-title":"Pharmacol Rev"},{"key":"2701_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ijpharm.2017.10.051","volume":"535","author":"SV Jermain","year":"2018","unstructured":"Jermain SV, Brough C, Williams RO. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery \u2013 an update. Int J Pharm. 2018;535:379\u201392.","journal-title":"Int J Pharm"},{"key":"2701_CR29","doi-asserted-by":"publisher","first-page":"7022","DOI":"10.3390\/molecules26227022","volume":"26","author":"F Oliveira","year":"2021","unstructured":"Oliveira F, Santos F, Duarte ARC. Therapeutic deep eutectic systems towards the treatment of tuberculosis and colorectal cancer: opportunities and challenges. Molecules. 2021;26:7022.","journal-title":"Molecules"},{"key":"2701_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.scp.2019.100192","volume":"14","author":"JM Silva","year":"2019","unstructured":"Silva JM, Silva E, Reis RL, Duarte ARC. A closer look in the antimicrobial properties of deep eutectic solvents based on fatty acids. Sustain Chem Pharm. 2019;14: 100192.","journal-title":"Sustain Chem Pharm"},{"key":"2701_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-33148-w","volume":"8","author":"B Olivares","year":"2018","unstructured":"Olivares B, Mart\u00ednez F, Rivas L, Calder\u00f3n C, Munita JM, Campodonico PR. A natural deep eutectic solvent formulated to stabilize \u03b2-lactam antibiotics. Sci Rep. 2018;8:1\u201312.","journal-title":"Sci Rep"},{"key":"2701_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/lam.13699","volume":"75","author":"F Al-Akayleh","year":"2022","unstructured":"Al-Akayleh F, Khalid RM, Hawash D, Al-Kaissi E, Al-Adham ISI, Al-Muhtaseb N, et al. Antimicrobial potential of natural deep eutectic solvents. Lett Appl Microbiol. 2022;75:607\u201315.","journal-title":"Lett Appl Microbiol"},{"key":"2701_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1134\/S1061933X22600488","volume":"85","author":"LR Yakupova","year":"2023","unstructured":"Yakupova LR, Kopnova TY, Skuredina AA, Le-Deygen IM, Shustrov PN, Novoselov AM, et al. The formation of \u03b2-cyclodextrin complexes with levofloxacin and ceftriaxone as an approach to the regulation of drugs\u2019 pharmacokinetic. Colloid J. 2023;85:114\u201327.","journal-title":"Colloid J"},{"key":"2701_CR34","doi-asserted-by":"crossref","unstructured":"Nasereddin J, Shakib M. Ira: a free and open-source Fourier transform infrared (FTIR) data analysis widget for pharmaceutical applications. Anal Lett. 2023;0:1\u201312.","DOI":"10.1080\/00032719.2023.2180516"},{"key":"2701_CR35","doi-asserted-by":"crossref","unstructured":"Maharini I, Martien R, Nugroho AK, Supanji, Adhyatmika. RP-HPLC-UV validation method for levofloxacin hemihydrate estimation in the nano polymeric ocular preparation. Arab J Chem. 2022;15:103582.","DOI":"10.1016\/j.arabjc.2021.103582"},{"key":"2701_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2021.101543","volume":"8","author":"P Bellio","year":"2021","unstructured":"Bellio P, Fagnani L, Nazzicone L, Celenza G. New and simplified method for drug combination studies by checkerboard assay. MethodsX. 2021;8: 101543.","journal-title":"MethodsX"},{"key":"2701_CR37","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1007\/s00253-019-09954-1","volume":"103","author":"H Abdel-Halim","year":"2019","unstructured":"Abdel-Halim H, Al Dajani A, Abdelhalim A, Abdelmalek S. The search of potential inhibitors of the AcrAB-TolC system of multidrug-resistant Escherichia coli: an in silico approach. Appl Microbiol Biotechnol. 2019;103:6309\u201318.","journal-title":"Appl Microbiol Biotechnol."},{"key":"2701_CR38","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1128\/AAC.00497-10","volume":"54","author":"MM Sopirala","year":"2010","unstructured":"Sopirala MM, Mangino JE, Gebreyes WA, Biller B, Bannerman T, Balada-Llasat JM, et al. Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2010;54:4678\u201383.","journal-title":"Antimicrob Agents Chemother"},{"key":"2701_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101159","volume":"53","author":"F Al-Akayleh","year":"2019","unstructured":"Al-Akayleh F, Mohammed Ali HH, Ghareeb MM, Al-Remawi M. Therapeutic deep eutectic system of capric acid and menthol: characterization and pharmaceutical application. J Drug Deliv Sci Technol. 2019;53: 101159.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2701_CR40","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1002\/jps.23200","volume":"101","author":"EM Gorman","year":"2012","unstructured":"Gorman EM, Samas B, Munson EJ. Understanding the dehydration of levofloxacin hemihydrate. J Pharm Sci. 2012;101:3319\u201330.","journal-title":"J Pharm Sci"},{"key":"2701_CR41","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1248\/cpb.43.649","volume":"43","author":"H Kitaoka","year":"1995","unstructured":"Kitaoka H, Wada C, Moroi R, Hakusui H. Effect of dehydration on the formation of levofloxacin pseudopolymorphs. Chem Pharm Bull (Tokyo). 1995;43:649\u201353.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"2701_CR42","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1021\/acs.cgd.8b00363","volume":"18","author":"JTJ Freitas","year":"2018","unstructured":"Freitas JTJ, De Melo CC, Viana OMMS, Ferreira FF, Doriguetto AC. Crystal structure of levofloxacin anhydrates: a high-temperature powder X-ray diffraction study versus crystal structure prediction. Cryst Growth Des. 2018;18:3558\u201368.","journal-title":"Cryst Growth Des"},{"key":"2701_CR43","doi-asserted-by":"publisher","unstructured":"Panini P, Rampazzo M, Singh A, Vanhoutte F, Van den Mooter G. Myth or truth: the glass forming ability class III drugs will always form single-phase homogenous amorphous solid dispersion formulations. Pharmaceutics. 2019;11:52911. https:\/\/doi.org\/10.3390\/pharmaceutics11100529.","DOI":"10.3390\/pharmaceutics11100529"},{"key":"2701_CR44","doi-asserted-by":"publisher","unstructured":"Li M, Yang Z, Zhang Y, Xu H, Zhang SH, Sun J, Wang J. Synthesis, crystal structure, and solubility study of a supramolecular assembly cocrystal formed by levofloxacin and nicotinic acid. J Mol Struct. 2022;1249:131549. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131549.\u200f","DOI":"10.1016\/j.molstruc.2021.131549"},{"key":"2701_CR45","unstructured":"DrugBank Online. Levofloxacin: uses, interactions, mechanism of action. https:\/\/go.drugbank.com\/drugs\/DB01137."},{"key":"2701_CR46","unstructured":"The National Center for Biotechnology Information (NCBI). Levofloxacin | C18H20FN3O4 | CID 149096 \u2013 PubChem. \nhttps:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Levofloxacin."},{"key":"2701_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2021.101093","volume":"82","author":"G Casillas-Vargas","year":"2021","unstructured":"Casillas-Vargas G, Ocasio-Malav\u00e9 C, Medina S, Morales-Guzm\u00e1n C, Del Valle RG, Carballeira NM, et al. Antibacterial fatty acids: an update of possible mechanisms of action and implications in the development of the next-generation of antibacterial agents. Prog Lipid Res. 2021;82: 101093.","journal-title":"Prog Lipid Res"},{"key":"2701_CR48","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.foodcont.2015.08.022","volume":"60","author":"SA Kim","year":"2016","unstructured":"Kim SA, Rhee MS. Highly enhanced bactericidal effects of medium chain fatty acids (caprylic, capric, and lauric acid) combined with edible plant essential oils (carvacrol, eugenol, \u03b2-resorcylic acid, trans-cinnamaldehyde, thymol, and vanillin) against Escherichia coli O157:H7. Food Control. 2016;60:447\u201354.","journal-title":"Food Control"},{"key":"2701_CR49","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jdermsci.2013.10.010","volume":"73","author":"WC Huang","year":"2014","unstructured":"Huang WC, Tsai TH, Chuang L, Te Li YY, Zouboulis CC, Tsai PJ. Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid. J Dermatol Sci. 2014;73:232\u201340.","journal-title":"J Dermatol Sci"},{"key":"2701_CR50","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1021\/acsbiomaterials.8b00486","volume":"4","author":"KN Ibsen","year":"2018","unstructured":"Ibsen KN, Ma H, Banerjee A, Tanner EEL, Nangia S, Mitragotri S. Mechanism of antibacterial activity of choline-based ionic liquids (CAGE). ACS Biomater Sci Eng. 2018;4:2370\u20139.","journal-title":"ACS Biomater Sci Eng"},{"key":"2701_CR51","doi-asserted-by":"publisher","first-page":"2200064","DOI":"10.1002\/gch2.202200064","volume":"6","author":"M Shevachman","year":"2022","unstructured":"Shevachman M, Mandal A, Gelston K, Mitragotri S, Joshi N, Shevachman M, et al. A long-lasting skin protectant based on CG-101, a deep eutectic solvent comprising choline and geranic acid. Global Challenges. 2022;6:2200064.","journal-title":"Global Challenges"},{"key":"2701_CR52","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/adhm.201600086","volume":"5","author":"M Zakrewsky","year":"2016","unstructured":"Zakrewsky M, Banerjee A, Apte S, Kern TL, Jones MR, Sesto RED, et al. Choline and geranate deep eutectic solvent as a broad-spectrum antiseptic agent for preventive and therapeutic applications. Adv Healthc Mater. 2016;5:1282\u20139.","journal-title":"Adv Healthc Mater"},{"key":"2701_CR53","doi-asserted-by":"publisher","unstructured":"Yang HT, Chen JW, Rathod J, Jiang YZ, Tsai PJ, Hung YP, et al. Lauric acid is an inhibitor of clostridium difficile growth in vitro and reduces inflammation in a mouse infection model. Front Microbiol. 2018;8. https:\/\/doi.org\/10.3389\/fmicb.2017.02635.","DOI":"10.3389\/fmicb.2017.02635"},{"key":"2701_CR54","doi-asserted-by":"publisher","first-page":"10223","DOI":"10.1021\/acs.langmuir.5b02088","volume":"31","author":"BK Yoon","year":"2015","unstructured":"Yoon BK, Jackman JA, Kim MC, Cho NJ. Spectrum of membrane morphological responses to antibacterial fatty acids and related surfactants. Langmuir. 2015;31:10223\u201332.","journal-title":"Langmuir"},{"key":"2701_CR55","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1128\/AAC.01043-13","volume":"58","author":"ML Cartron","year":"2014","unstructured":"Cartron ML, England SR, Chiriac AI, Josten M, Turner R, Rauter Y, et al. Bactericidal activity of the human skin fatty acid cis-6-hexadecanoic acid on Staphylococcus aureus. Antimicrob Agents Chemother. 2014;58:3599.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-023-02701-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-023-02701-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-023-02701-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T07:03:10Z","timestamp":1703919790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-023-02701-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2701"],"URL":"https:\/\/doi.org\/10.1208\/s12249-023-02701-w","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"assertion":[{"value":"20 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"244"}}